Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma

NCT00151281 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: PEPC
DRUG: Thalidomide
DRUG: Rituximab

Sponsor

Weill Medical College of Cornell University